121 related articles for article (PubMed ID: 43483)
1. Pharmacological and biochemical aspects of hyperkinetic disorders.
Leonard BE
Neuropharmacology; 1979 Dec; 18(12):923-9. PubMed ID: 43483
[No Abstract] [Full Text] [Related]
2. The paradox effect of psychostimulants in the treatment of the child hyperkinetic syndrome.
Drtílková I; Misurec J; Náhunek K
Act Nerv Super (Praha); 1990 Dec; 32(4):302-3. PubMed ID: 1982036
[No Abstract] [Full Text] [Related]
3. Interaction of genetics and separation in canine hyperkinesis and in differential responses to amphetamine.
Corson SA; Corson EO; Becker RE; Ginsburg BE; Trattner A; Connor RL; Lucas LA; Panksepp J; Scott JP
Pavlov J Biol Sci; 1980; 15(1):5-11. PubMed ID: 7191082
[No Abstract] [Full Text] [Related]
4. [Stimulants in the treatment of hyperkinetic behavior disorders].
Barkai A
Harefuah; 1971 Mar; 80(6):298-302. PubMed ID: 4946564
[No Abstract] [Full Text] [Related]
5. Amphetamines in the management of children's hyperkinesis.
Singh V; Ling GM
Bull Narc; 1979; 31(3-4):87-94. PubMed ID: 44685
[No Abstract] [Full Text] [Related]
6. Treating problem children with stimulant drugs.
Sroufe LA; Stewart MA
N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
[No Abstract] [Full Text] [Related]
7. "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology.
Robbins TW; Sahakian BJ
Neuropharmacology; 1979 Dec; 18(12):931-50. PubMed ID: 43484
[No Abstract] [Full Text] [Related]
8. Clinical utility of animal models of childhood hyperkinesis.
Camp JA; Winsberg BG
Clin Neuropharmacol; 1984; 7(3):185-221. PubMed ID: 6149019
[No Abstract] [Full Text] [Related]
9. Psychopharmacologic facilitation of psychosocial therapy of violence and hyperkinesis.
Corson SA; Corson EO
Act Nerv Super (Praha); 1988 Jan; 30(1):22-39. PubMed ID: 2898193
[TBL] [Abstract][Full Text] [Related]
10. Management of hyperkinetic behavior in children with epilepsy.
Millichap JG
Mod Treat; 1969 Nov; 6(6):1233-46. PubMed ID: 4393565
[No Abstract] [Full Text] [Related]
11. How do hyperactive children feel about taking stimulants and will they tell the doctor?
Sleator EK; Ullmann RK; von Neumann A
Clin Pediatr (Phila); 1982 Aug; 21(8):474-9. PubMed ID: 6123398
[No Abstract] [Full Text] [Related]
12. Proceedings: Dose effects of stimulants in hyperkinetic children.
Sleator EK; Sprague RL
Psychopharmacol Bull; 1974 Oct; 10(4):29-33. PubMed ID: 4154470
[No Abstract] [Full Text] [Related]
13. The hyperkinetic child and stimulant drugs.
Eisenberg L
N Engl J Med; 1972 Aug; 287(5):249-50. PubMed ID: 4402576
[No Abstract] [Full Text] [Related]
14. Help for the hyperkinetic child in school.
Harlin VK
J Sch Health; 1972 Dec; 42(10):587-92. PubMed ID: 4404642
[No Abstract] [Full Text] [Related]
15. Use of d-amphetamine and related central nervous system stimulants in children.
Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865
[No Abstract] [Full Text] [Related]
16. [Efficacy of pantogam in the treatment of hyperkinetic disorders in children].
Sukhotina NK; Konovalova VV; Kryzhanovskaia IL; Kupriianova TA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):24-8. PubMed ID: 21311483
[TBL] [Abstract][Full Text] [Related]
17. Drugs in management of hyperkinetic and perceptually handicapped children.
Millichap JG
JAMA; 1968 Nov; 206(7):1527-30. PubMed ID: 4386794
[No Abstract] [Full Text] [Related]
18. Neurophysiologic proposal for the amphetamine response in hyperkinetic children.
Buckley RE
Psychosomatics; 1972; 13(2):93-99. PubMed ID: 4671944
[No Abstract] [Full Text] [Related]
19. Amphetamines in hyperkinetic children.
Tec L; Levy HB
JAMA; 1971 Jun; 216(11):1864-5. PubMed ID: 5108576
[No Abstract] [Full Text] [Related]
20. Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children.
Saletu B; Saletu M; Simeon J; Viamontes G; Itil TM
Biol Psychiatry; 1975 Jun; 10(3):253-75. PubMed ID: 1095081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
